The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Organizer: Satohiro Masuda (Himeji Dokkyo Univ.), Hiroki Itoh (Oita Univ. Hosp. Dept. Pharmacy), Ryuji Ikeda (Univ. Miyazaki Hosp. Dept. Pharmacy), Hirofumi Jono (Dept. Pharm. Sci., Kumamoto Univ. Hosp.)

With innovative advancements in drug-discovery technology, large numbers of therapeutic target molecules have recently been identified. Although molecular-targeted agents that modulate the function of target molecules have been widely used in clinical settings, multiple trials and errors are often necessary for proper medication due to a lack of enough clinical evidence, especially in new innovative pharmacotherapies. Therefore, clinical pharmacists are required to provide novel clinical evidence in medical settings.
In this symposium, we would like to present the latest topics and their backgrounds concerning the basic and clinical research conducted by clinical pharmacists working in clinical settings, and discuss the current status of research conducted by hospital pharmacists, their issues, and future development, in order to consider the meaning and importance of research activities.